CatalYm GmbH logo

CatalYm GmbH

Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.

58 employees · est. 2016 · Germany

VS
Navio logo

Navio

We’re changing the narrative around cancer

1 employees · est. 2018 · San Francisco, United States

CatalYm GmbH is the older company (2016 vs 2018); CatalYm GmbH is the larger of the two.

Side-by-Side Comparison

CatalYm GmbH Navio
Founded
2016 older 2018
Headquarters
Germany San Francisco, United States
Employees
58 larger 1
Industry
Biotechnology, Health Care, Health and Wellness Digital Health, Health Care, Information Technology
Funding Stage
Series D Series B
Total Funding
$250.00M $25.40M
Funding Rounds
4 1
Services
Development of immunotherapies targeting GDF-15, Conducting clinical trials for cancer treatment, Advancing drug candidates for cachexia associated with cancer Not tracked yet
Target Customers
Oncologists, Cancer Centers, Pharmaceutical Companies, Healthcare Providers Not tracked yet
Taxonomy
Immunotherapy, Cancer Treatment, Oncology, Antibody Development, Tumor Microenvironment, GDF-15 Targeting, Solid Tumors, Neutralizing Antibodies, Immune System Engagement, Placental Factor Overproduction, CT-002 Program, Clinical Proof-of-Concept, Therapeutic Innovation, Tumor-Specific Treatment Cancer Treatment, Patient Support, Brain Tumor, Clinical Trials, Healthcare App, Treatment Management, Caregiver Support
Website
catalym.com navio.com
CatalYm GmbH logo

About CatalYm GmbH

CatalYm GmbH, founded in 2016, is a Germany-based company deeply embedded in the Biotechnology and Health Care sectors. The company's mission—"Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems"—captures its commitment to advancing medical...

Navio logo

About Navio

Navio is a United States-based startup founded in 2018. The company's mission is to change the narrative around cancer. It offers healthcare providers early access to treatment timelines that can save time and improve patient experience, while providing a free app for patients and caregivers to mana...

We will tell you when either one moves

BounceWatch watches CatalYm GmbH and Navio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CatalYm GmbH and Navio — by email.

Frequently Asked Questions

CatalYm GmbH — Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.. Navio — We’re changing the narrative around cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CatalYm GmbH has raised $250.00M while Navio has raised $25.40M.
CatalYm GmbH and Navio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CatalYm GmbH with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CatalYm GmbH on 28 May 2026, and Navio on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy